Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy

Vasant Jayasankar, Timothy J. Pirolli, Lawrence T. Bish, Mark F. Berry, Jeffrey Burdick, Todd Grand, Y. Joseph Woo

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Background. - Post-infarction heart failure is characterized by progressive left ventricular dilatation and wall thinning, with both systolic and diastolic cardiac dysfunction. Human growth hormone (GH) stimulates cardiac hypertrophy when secreted in excess and directly enhances cardiomyocyte contractile function. We hypothesized that local myocardial overexpression of GH could prevent ventricular remodeling and heart failure following myocardial infarction (MI) in rats. Methods and Results. - Rats underwent ligation of the left anterior descending coronary artery with direct intramyocardial injection of adenovirus encoding human GH (n = 8) or null virus as control (n = 8). Six weeks following MI, Adeno-GH treated animals had significant preservation of both systolic and diastolic cardiac function compared to Null animals (maximum dP/dt GH 2927 ± 83 vs Null 1622 ± 159 mmHg/sec, p < 0.001; minimum dP/dt -2409 ± 82 vs -1195 ± 179 mmHg/sec, p < 0.01). GH animals had improved ventricular geometry with decreased chamber dilatation (13.2 ± 0.13 vs 14.4±0.15 mm, p < 0.001) and increased wall thickness (2.02 ± 0.10 vs 1.28 ± 0.07 mm, p < 0.001), and this was associated with advantageous myocardial hypertrophy with increased cardiomyocyte fiber size. Local myocardial overexpression of GH protein was seen in Adeno-GH animals, while serum levels of human GH were undetectable after 6 weeks. Conclusions. - Treatment with Adeno-GH following MI resulted in reduced ventricular dilatation, increased local myocardial hypertrophy, and preservation of both systolic and diastolic cardiac function. No significant systemic exposure to growth hormone transgene was observed. The induction of regional hypertrophy is a novel approach to treating heart failure, and may be useful to treat or prevent post-infarction ischemic cardiomyopathy.

Original languageEnglish (US)
Pages (from-to)531-538
Number of pages8
JournalJournal of Molecular and Cellular Cardiology
Volume36
Issue number4
DOIs
StatePublished - Apr 1 2004

Keywords

  • Gene therapy
  • Growth factors
  • Heart failure
  • Remodeling

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Targeted overexpression of growth hormone by adenoviral gene transfer preserves myocardial function and ventricular geometry in ischemic cardiomyopathy'. Together they form a unique fingerprint.

  • Cite this